rs363125
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001388492.1(HTT):c.5159C>A(p.Thr1720Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.119 in 1,611,318 control chromosomes in the GnomAD database, including 16,012 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in UniProt.
Frequency
Consequence
NM_001388492.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.194 AC: 29494AN: 151990Hom.: 4408 Cov.: 32
GnomAD3 exomes AF: 0.119 AC: 29785AN: 249434Hom.: 2767 AF XY: 0.117 AC XY: 15832AN XY: 135332
GnomAD4 exome AF: 0.111 AC: 162432AN: 1459210Hom.: 11579 Cov.: 30 AF XY: 0.110 AC XY: 80088AN XY: 726110
GnomAD4 genome AF: 0.194 AC: 29560AN: 152108Hom.: 4433 Cov.: 32 AF XY: 0.190 AC XY: 14150AN XY: 74346
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at